However, apparent inconsistencies between the observed status of TGFβ signaling in aneurysm tissue and the known consequences of LDS and MFS mutations on signaling activity have remained a source of confusion and controversy in the field (Cook et al., 2015; Mallat et al., 2017; Wei et al., 2017). This evidence concerns the gene TGFB1 and aneurysm.